The projected savings from Trump's "most-favored nation" pricing policy might be drastically reduced by secretive deals with ...
A late-stage clinical trial found that, when combined with an SMN2-targeting drug, Isembyld caused young patients’ motor ...
U.S. officials declare an end to record-setting cyclospora outbreak, but its origin is still unknown
The largest cyclospora food poisoning outbreak in U.S. history is over, U.S. health officials said, but questions remain over ...
The back-to-back failures of cardiovascular drugs from Novartis and Novo Nordisk made headlines. They could also have a ...
A pill from AstraZeneca failed to improve outcomes in closely watched breast cancer study, a result that could limit the use ...
A newly approved AI tool can scan EKGs for severe heart attacks and, the company says, for rarer patterns indicating blocked ...
Platinum chemotherapy's long-term effects, surprising heart failure drug failures, and more biotech news from The Readout ...
New Medicaid rules use allow use of tiers to determine work exemptions. Advocates fear complex guidelines could cause ...
For thousands of families, the Sept. 11 attack did not end when the fires were extinguished. It simply changed form,” writes ...
About four dozen children who attended a community party in August 2025 later developed skin and soft tissue lesions and ...
When the FDA approved a new pancreatic cancer drug called Rasonque, researchers celebrated. But some patients hoping for ...
Rural health systems are seeking partnership to survive, fueling a debate over competition and the rising cost of medical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results